drugset / Trial / NCT01652885
Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the safety, tolerability, and systemic exposure of AN2728 Topical Ointment, 2%, in subjects with atopic dermatitis.
Timeline
- Start
- 2012-07
- Primary completion
- 2012-10
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Crisaborole | Small molecule | 2 % | Topical |